medigraphic.com
Colegio de Medicina Interna de México.

2022, Number 6

<< Back Next >>

Med Int Mex 2022; 38 (6)

Acute hepatitis of unknown origin in children. What is the cause?

García-Ferrera W, Villafuerte-Tunaal I, Mexia-Arellano AL

Language: Spanish
References: 13
Page: 1263-1266
PDF size: 176.03 Kb.


ABSTRACT

The World Health Organization has issued a report on 228 cases of acute hepatitis of unknown cause in children between 1 month and 16 years, 10% of them required liver transplantation and 4 died (3 in Indonesia), another 50 cases are under investigation. The adenovirus type 41 is one of the causative agents of acute gastroenteritis in children, characterized by diarrhea, vomiting and fever, often accompanied by respiratory symptoms. Cases of hepatitis in immunocompromised children have been documented; however, there is no available evidence to indicate that adenovirus type 41 can cause hepatitis in healthy children. Although adenovirus is currently hypothesized as the underlying cause, it does not fully explain the severity of the clinical picture. Given this new situation, we have more questions than answers, the reported cases had no apparent risk factors, most had not received the COVID-19 vaccine. Several hypotheses are being evaluated and it seems that the infectious cause is more solid. The possible role of previous SARS-CoV-2 infection in children reported with acute hepatitis is analyzed.


REFERENCES

  1. Braccio S, Irwin A, Riordan A, Shingadia D, Kelly DA, BansalS, Ramsay M, Ladhani SN. Acute infectious hepatitis inhospitalised children: a British Paedriatic Surveillance Unitstudy. Arch Dis Child 2017; 102 (7): 624-628. https://doi.org/10.1136/archdischild-2016-311916

  2. Marsh K, Tayler R, Pollock L, Roy K, Lakha F, Ho A, HendersonD, Divala T, Curri S, Yirrel D, Rossi MK, Phin N.Investigation into cases of hepatitis of unknown aetiologyamong young children, Scotland, 1 January 2022 to 12 April2022. Euro Surveill 2022; 27 (15). doi: 10.2807/1560-7917.ES.2022.27.15.2200318.

  3. US Centers for Disease Control (US-CDC). CDC alerts healthcare providers to cases of hepatitis of unknown origin. April21, 2022. Available at: https://bit.ly/3rV1n6R.

  4. Baker JM, Buchfellner M, Britt W, Sanchez V, et al. Acute hepatitisand adenovirus infection among children-Alabama,October 2021-February 2022. MMWR Morb Mortal WklyRep 2022; 71: 638-640. DOI: http://dx.doi.org/10.15585/mmwr.mm7118e1.

  5. Kang G. Viral diarrhea. In: Cambridge, MA: Elselvier;2017: 360-7 https://www.sciencedirect.com/referencework/9780128037089/international-encyclopedia-ofpublich-health.

  6. Hierholzer JC. Adenoviruses in the immunocompromisedhost. Clin Microbiol Rev 1992; 5 (3): 262-74. doi: 10.1128/CMR.5.3.262.

  7. Lynch JP 3rd, Kajon AE. Adenovirus: Epidemiology, globalspread of novel types, and approach to treatment. SeminRespir Crit Care Med 2021; 42: 800-821. https://doi.org/10.1055/s-0041-1733802.

  8. World Health Organization. Disease Outbreak News; Multi-Country—Acute, Severe Hepatitis of Unknown Origin inChildren. 23 April 2022. Available online: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON376 (accessed on 28 April 2022).

  9. European Centre for Disease Prevention and Control Increasein severe acute hepatitis cases of unknown aetiologyin children-28 Abril 2022.https://www.ecdc.europa.eu/en/publications-data/increase-severe-acute-hepatitis-casesunknown-aetiology-children. Data accessed: May 12,2022.

  10. Cevik M, Rasmussen A L, Bogoch II, Kindrachuck J. Acutehepatitis of unknown origin in children. BMJ 2022; 377:o1197. doi:10.1136/bmj.O1197.

  11. Brodin P, Arditi M. Severe acute hepatitis in children:investigate SARS-CoV-2 superantigens. Lancet GastroenterolHepatol 2022. https://doi.org/10.1016/S2468-

  12. 1253(22)00166-2.12. Porritt RA, Paschold L, Rivas MN, Chen MH, Yonker LM,Chandnani H, Lopez M, Simnica D, Schulttheib C, SantiskulvongC, Van Eyk J, McCormick JK, Fasano A, Bahar I, etal. HLA class I-associated expansion of TRBV11-2 cells inmultisystem inflammatory syndrome in children. J ClinInvest 2021; 131 (10): e146614. doi:10.1172/JCI146614.

  13. Yarovinsky TO, Mohning MP, Bradford MA, Monick MM,Hunninghake GW. Increased sensitivity to staphylococcalenterotoxin B following adenoviral infection. Infect Immun2005; 73 (6): 3375-84. doi: 10.1128/IAI.73.6.3375-3384.2005.




2020     |     www.medigraphic.com